Table 5.
Intervention effects on lifestyle, health behaviors, and quality-of-life outcomes.
| Intervention effects on lifestyle, health behaviors, and quality-of-life | PATHwaya, mean (SD) | Usual care, mean (SD) | Effect size | P value | |||||||||
|
|
Baseline | 6 months | Baseline | 6 months |
|
|
|||||||
| Mediators of change in physical activity (N=120) | |||||||||||||
|
|
Exercise intentions | 21.3 (2.57) | 20.5 (3.06) | 21.1 (2.67) | 20.7 (3.52) | 0.14 | .48 | ||||||
|
|
Exercise planning | 27.3 (6.30) | 28.3 (6.98) | 28.4 (5.83) | 28.1 (6.73) | 0.14 | .19 | ||||||
|
|
Exercise barriers (barriers self-efficacy scale) | 68.1 (23.1) | 67.3 (22.5) | 70.5 (21.5) | 68.9 (22.8) | 0.04 | .83 | ||||||
|
|
Exercise self-efficacy (exercise self-efficacy scale) | 83.3 (17.7) | 78.3 (18.3) | 81.1 (19.1) | 79.7 (20.0) | −0.23 | .24 | ||||||
|
|
Social support (ENRICHDb social support instrument) | 27.3 (3.56) | 27.2 (3.95) | 27.0 (3.36) | 27.0 (3.61) | −0.02 | .94 | ||||||
| Lifestyle assessment (N=120) | |||||||||||||
|
|
Diet (Mediterranean diet adherence screener) | 6.47 (2.12) | 6.35 (1.93) | 5.95 (2.08) | 6.20 (2.15) | −0.20 | .25 | ||||||
|
|
Medication adherence (Morisky medication adherence scale) | 6.78 (0.98) | 6.70 (0.89) | 6.70 (1.01) | 6.78 (0.87) | −0.09 | .30 | ||||||
|
|
Stress (perceived stress scale) | 11.4 (7.22) | 10.9 (7.84) | 11.9 (6.35) | 11.6 (6.98) | −0.011 | .86 | ||||||
|
|
Alcohol consumption (alcohol use disorders identification test) | 3.23 (2.53) | 3.10 (2.43) | 2.90 (2.01) | 3.08 (2.29) | −0.38 | .08 | ||||||
| Quality of life (N=120) | |||||||||||||
|
|
Health-related quality of life (short form 36) | 76.9 (16.5) | 77.0 (18.2) | 75.0 (16.2) | 76.1 (18.3) | −0.11 | .60 | ||||||
|
|
Perceived health (perceived health questionnaire) | 3.25 (3.76) | 3.43 (4.79) | 3.17 (3.34) | 3.27 (4.21) | −0.28 | .86 | ||||||
|
|
Mental well-being (Warwick-Edinburgh mental well-being scale) | 56.9 (9.42) | 57.0 (10.1) | 55.0 (8.50) | 57.0 (9.65) | 0.06 | .06 | ||||||
aPATHway: Physical Activity Toward Health.
bENRICHD: Enhancing Recovery in Coronary Heart Disease.